Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 4,388 | 7,763 | 7,810 | 10,442 | 14,863 |
| Operating Income | -4,388 | -7,763 | -7,810 | -10,442 | -14,863 |
| Other Income | -8,251 | 2,742 | 6,743 | -11,771 | 147 |
| Pre-tax Income | -12,638 | -5,020 | -1,067 | -22,213 | -14,717 |
| Net Income Continuous | -12,638 | -5,020 | -1,067 | -22,213 | -14,717 |
| Net Income | $-12,638 | $-5,020 | $-1,067 | $-22,213 | $-14,717 |
| EPS Basic Total Ops | -0.97 | -0.44 | -0.10 | -2.34 | -1.63 |
| EPS Basic Continuous Ops | -0.97 | -0.44 | -0.10 | -2.34 | -1.63 |
| EPS Diluted Total Ops | -0.97 | -0.44 | -0.72 | -2.34 | -1.63 |
| EPS Diluted Continuous Ops | -0.97 | -0.44 | -0.10 | -2.34 | -1.63 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.44 | -0.72 | -1.09 | -1.63 |
| EBITDA(a) | $-4,388 | $-7,763 | $-7,810 | $-10,442 | $-14,863 |